Nice article published online yesterday by FNArena. Here's the gist:
Heading:
Avexa Looks Cheap
FN Arena News - June 20 2007
ABN Amro Morgans believes that Avexa is cheap at 57c and provides a significant buying opportunity. They have a 12-month target price of $1.42.
They mention Avexa's timetable of upcoming milestones , including trial results to be published at the International Aids Society conference in Sydney next month, a Phase III testing sites to be initiated in the second half of '07, and a paediatrics trial will commence. They predict that these milestones will all have a positive impact on the share price.
Says ABN Amro Morgans: "The current share price weakness creates a buying opportunity. The company is well funded with approximately A$80m in cash, sufficient to fund the Phase 3 trials for its HIV compound."
- Forums
- ASX - By Stock
- AVX
- bounce predicted
bounce predicted
-
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online